Granted Patent
B2
US 10,017,453 · App. 14/543,638 · Granted Jul 10, 2018
Pharmaceutically acceptable salts of fatty acids
Assignee:
DS BIOPHARMA LIMITED
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.
Claims (5)
1. A lysine salt form of 15-hydroxy-8(Z),11(Z),13(E)-eicosatrienoic acid (15-HETrE).
2. A pharmaceutical composition comprising a lysine salt form of 15 hydroxy-8(Z),11(Z),13(E)-eicosatrienoic acid (15-HETrE).
3. The pharmaceutical composition of claim 2 further comprising an excipient.
4. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is in a form suitable for topical administration.
5. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is suitable for oral administration.
Assignments (2)
CHANGE OF NAME
Recorded Jul 31, 2017
From: DIGNITY SCIENCES LIMITED
To: DS BIOPHARMA LIMITED
Reel/Frame 043147/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 19, 2014
From: MANKU, MEHAR; COUGHLAN, DAVID; DOWNES, BILL
To: DIGNITY SCIENCES LIMITED
Reel/Frame 034213/0085 →
Continuity (2)
Provisional Application
61904600
· Nov 15, 2013